Minerva Surgical, Inc. (UTRS)

OTCMKTS: UTRS · Delayed Price · USD

0.460

-0.050 (-9.80%)

Apr 18, 2024, 1:44 PM EDT - Market open

Minerva Surgical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019
Net Income	-34.11	-21.46	-18.26	-69.8
Depreciation & Amortization	10.81	10.62	7.08	1.68
Share-Based Compensation	6.98	6.82	0.86	0.59
Other Operating Activities	-19.24	-18.35	-1.91	47.74
Operating Cash Flow	-35.57	-22.38	-12.24	-19.79
Capital Expenditures	-0.07	-0.58	-0.45	-0.22
Acquisitions	0	0	-15	0
Other Investing Activities	-	-25	-	-
Investing Cash Flow	-0.07	-25.58	-15.45	-0.22
Common Stock Issued	0.04	70.73	0.12	0.11
Other Financing Activities	-5	0.49	17.96	43.05
Financing Cash Flow	-4.96	71.21	18.08	43.16
Net Cash Flow	-40.6	23.25	-9.62	23.14
Free Cash Flow	-35.64	-22.96	-12.69	-20.02
Free Cash Flow Margin	-70.86%	-44.07%	-33.61%	-76.95%
Free Cash Flow Per Share	-24.74	-65.49	-12.45	-21.59

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.